Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition
Status:
Withdrawn
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This is a double blinded randomized clinical trial of Alanyl-Glutamine or Glycine in children
with persistent diarrhea or malnutrition. The primary objective of the study is to determine
the effect of 7 days of supplementation of alanyl-glutamine as it compares to glycine on the
damaged intestinal barrier function, measured by lactulose/mannitol test on day 8, in
children at HIAS in Fortaleza, Ce, Brazil, with persistent diarrhea (history > 2 weeks
duration) or malnutrition.
Phase:
Phase 3
Details
Lead Sponsor:
University of Virginia
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)